10.6084/m9.figshare.7975223.v1
Xiaotong Li
Xiaotong
Li
Sarah Warren
Sarah
Warren
Vasiliki Pelekanou
Vasiliki
Pelekanou
Vikram Wali
Vikram
Wali
Alessandra Cesano
Alessandra
Cesano
Mingdong Liu
Mingdong
Liu
Patrick Danaher
Patrick
Danaher
Nathane Elliott
Nathane
Elliott
Zeina Nahleh
Zeina
Nahleh
Daniel Hayes
Daniel
Hayes
Gabriel Hortobagyi
Gabriel
Hortobagyi
William Barlow
William
Barlow
Christos Hatzis
Christos
Hatzis
Lajos Pusztai
Lajos
Pusztai
Additional file 4: of Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial
Springer Nature
2019
Tumor infiltrating lymphocytes
PD-L1
Immune-related genes
Neoadjuvant treatment
Bevacizumab
2019-04-10 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_4_of_Immune_profiling_of_pre-_and_post-treatment_breast_cancer_tissues_from_the_SWOG_S0800_neoadjuvant_trial/7975223
Figure S4. Correlation between TIL counts and PD-L1 expression. A. Correlation between TIL counts and PD-L1 expression on tumor cells. B. Correlation between TIL counts and PD-L1 expression on stromal cells. C. TIL counts in cases with positive and negative PD-L1 expression on tumor cells. D. TIL counts in cases with positive and negative PD-L1 expression on stromal cells. For A and B, Solid line and grey shade represent linear regression line and 95% confidence interval, respectively. Besides, Pearson correlation coefficient r and p-value are added. For C and D, p values are from Wilcoxon test. (PDF 74 kb)